In contrast, within the context of glioma, ALOX5 has been shown to facilitate disease progression by promoting 5-HETE-mediated immunosuppressive M2 polarization and elevating PD-L1 expression in glioma-associated microglia/macrophages (Chen T. et al., 2024). This evidence concerns the gene ALOX5 and central nervous system cancer.